Actively Recruiting
A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC
Led by Hunan Province Tumor Hospital · Updated on 2023-12-27
200
Participants Needed
1
Research Sites
135 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
CONDITIONS
Official Title
A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must be 18 years or older
- Provide fully informed consent before any study procedures
- Have untreated, histologically confirmed resectable stage II, IIIA, or IIIB (N2) NSCLC (AJCC stage VIII), confirmed by PET-CT or biopsy
- Resectable stage II NSCLC defined by assessment of radical resection by a qualified thoracic surgeon
- Resectable and potentially resectable stages defined by Expert Consensus on Stage III NSCLC (2019 version)
- Resectable includes IIIA (N0-1), some single-station mediastinal lymph node metastases with N2, and some T4 (satellite nodules in adjacent lobes) N1
- Potentially resectable includes some IIIA and IIIB, including single-station N2 mediastinal lymph nodes < 3 cm, stage IIIA NSCLC, and potentially resectable T3 or T4 central tumors
- Solid or solid pulmonary nodules strongly recommended for pathological puncture verification
- Have at least one measurable lesion per RECIST 1.1
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hunan Cancer Hospital
Changsha, Hunan, China, 410013
Actively Recruiting
Research Team
Y
Yongchang Zhang, MD
CONTACT
N
Nong Yang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here